AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Companies sign distribution agreement for NMP22 Test Kit.

Biotech Business Week

| July 05, 2004 | COPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2004 JUL 5 - (NewsRx.com & NewsRx.net) -- Matritech, Inc., (MZT), a developer of protein-based diagnostic products for the early detection of cancer, and Wampole Laboratories, LLC, a wholly owned subsidiary of Inverness Medical Innovations, Inc., announced an agreement for the distribution of Matritech's NMP22 Test Kit.

Under the terms of the agreement, Wampole will receive exclusive rights to distribute the NMP22 ELISA (Enzyme Linked Immunosorbent Assay) Test Kit to hospitals and clinical reference laboratories in the United States. Matritech's own sales force will continue to sell the NMP22 BladderChek Test directly to urologists in their offices.

"Wampole's proven ability to market and distribute products to hospitals and reference laboratories and their leadership position in ELISA testing made them an obvious choice for marketing our NMP22 Test Kit. Given the synergistic relationship between the NMP22 BladderChek Test and the NMP22 Test Kit, we have seen an increase in the number of lab tests being performed as the number of NMP22 BladderChek Tests has risen. As our own sales force continues to increase sales to the urologist, we ...

Related articles from newspapers, magazines, journals, and more
Wampole Laboratories Signs Agreement to Acquire Exclusive U.S. Distribution...
Press release article from: Business Wire August 18, 2003 700+ words
...Membrane Point-of Care Diagnostics Wampole Laboratories, a division of Inverness Medical...rights to the Efoora Rapid HIV test. Wampole Laboratories (Princeton, NJ) is a leading...Under the terms of the agreement, Wampole Laboratories will have exclusive distribution...
Wampole Laboratories signs agreement to acquire exclusive US distribution...
News wire article from: Asia Africa Intelligence Wire August 18, 2003 700+ words
...Business NewsBase - Press Release) Wampole Laboratories, a division of Inverness Medical...Under the terms of the agreement, Wampole Laboratories will have exclusive distribution...rapid HIV test further strengthens Wampole Laboratories' presence in the rapid membrane...
Clearview ULTRA FOB Now Available; Inverness Medical Innovations and Subsidiary...
Press release article from: PR Newswire March 10, 2005 700+ words
...Innovations, Inc., and its subsidiary, Wampole Laboratories, LLC, announces the availability...Bridgen, Ph.D., president, Wampole Laboratories. The American Cancer Society...to about 40,000 deaths. About Wampole Laboratories Wampole Laboratories is committed...
Calypte Biomedical Announces Collaboration with Wampole Laboratories and...
Press release article from: Business Wire January 24, 2000 700+ words
...entered into a collaboration with Wampole Laboratories, a division of Carter Wallace...Calypte Biomedical Corporation. Wampole Laboratories, which was appointed as Calypte...uot; John Bridgen, President of Wampole Laboratories, said, &uot;Wampole...
MedPointe Announces Sale of Wampole Laboratories; Inverness Medical Innovations...
Press release article from: Business Wire August 8, 2002 700+ words
...MedPointe's medical diagnostics division, Wampole Laboratories. The $70 million cash transaction, which has...information on MedPointe, Wallace Pharmaceuticals or Wampole Laboratories, visit www.medpointeinc.com.
MedPointe Completes Sale of Wampole Laboratories; Inverness Medical Innovations...
Press release article from: Business Wire September 23, 2002 700+ words
...announced that it has completed the divestiture of its Wampole Laboratories medical diagnostics division to Inverness Medical Innovations...8. Under the terms of the sale, Inverness purchased Wampole Laboratories and all of the assets required to operate its business...
MeadPointe (Somerset, New Jersey) completed the divestiture of its Wampole...
Newspaper article from: Diagnostics & Imaging Week September 26, 2002 700+ words
...Somerset, New Jersey) completed the divestiture of its Wampole Laboratories (Princeton, New Jersey) medical diagnostics division...transaction was first reported Aug. 8. Inverness purchased Wampole Laboratories and all of the assets required to operate its business...
Inverness Medical Innovations (Waltham, Massachusetts), a manufacturer and...
Newspaper article from: Diagnostics & Imaging Week May 26, 2005 700+ words
...and professional markets, said that its subsidiary, Wampole Laboratories (Princeton, New Jersey), has signed an agreement...test on the market," said John Bridgen, president of Wampole Laboratories. The Centers for Medicare & Medicaid Services...
CLARK LABORATORIES AND WAMPOLE LABORATORIES DISCUSSING MARKETING AND...
Press release article from: PR Newswire July 31, 1995 700+ words
...Laboratories, Inc., announced today that it had entered into a non-binding Letter of Intent to provide the Wampole Laboratories Division of Carter-Wallace, Inc. (NYSE: CAR), with exclusive domestic marketing rights to its entire...
Inverness Medical Innovations' subsidiary Wampole Laboratories announces...
News wire article from: Asia Africa Intelligence Wire July 11, 2005 700+ words
...Business NewsBase - Press Release) Inverness Medical Innovations Inc (Inverness) announced that its subsidiary Wampole Laboratories (Wampole) has signed an agreement with Roche Diagnostics to collaborate on the first fully automated diagnostic...
For more facts and information, see all results

Source: HighBeam Research, Companies sign distribution agreement for NMP22 Test Kit.

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA